Abstract:Multiple sclerosis is characterized by demyelination and neuronal loss caused by inflammatory cell activation and infiltration into the central nervous system. Macrophage polarization plays an important role in the pathogenesis of experimental autoimmune encephalomyelitis, a traditional experimental model of multiple sclerosis. This study investigated the effect of Fasudil on macrophages and examined the therapeutic potential of Fasudil-modified macrophages in experimental autoimmune encephalomyelitis. We found that Fasudil induced the conversion of macrophages from the pro-inflammatory M1 type to the anti-inflammatory M2 type, as shown by reduced expression of inducible nitric oxide synthase/nitric oxide, interleukin-12, and CD16/32 and increased expression of arginase-1, interleukin-10, CD14, and CD206, which was linked to inhibition of Rho kinase activity, decreased expression of toll-like receptors, nuclear factor-κB, and components of the mitogen-activated protein kinase signaling pathway, and generation of the pro-inflammatory cytokines tumor necrosis factor-α, interleukin-1β, and interleukin-6. Crucially, Fasudil-modified macrophages effectively decreased the impact of experimental autoimmune encephalomyelitis, resulting in later onset of disease, lower symptom scores, less weight loss, and reduced demyelination compared with unmodified macrophages. In addition, Fasudil-modified macrophages decreased interleukin-17 expression on CD4+ T cells and CD16/32, inducible nitric oxide synthase, and interleukin-12 expression on F4/80+ macrophages, as well as increasing interleukin-10 expression on CD4+ T cells and arginase-1, CD206, and interleukin-10 expression on F4/80+ macrophages, which improved immune regulation and reduced inflammation. These findings suggest that Fasudil-modified macrophages may help treat experimental autoimmune encephalomyelitis by inducing M2 macrophage polarization and inhibiting the inflammatory response, thereby providing new insight into cell immunotherapy for multiple sclerosis.

Nasal administration of fasudil-modified mononuclear cells showed multitarget therapeutic effect on experimental autoimmune encephalomyelitis

Nasal Delivery of Fasudil-modified Immune Cells Exhibits Therapeutic Potential in Experimental Autoimmune Encephalomyelitis.

[Immunoregulative Effect of Fasudil on Encephalomyelitic T Cells in Experimental Autoimmune Encephalomyelitis Mice].

Fasudil Mediates Cell Therapy of EAE by Immunomodulating Encephalomyelitic T Cells and Macrophages.

Effect of Fasudil on Miroglia and Astrocytes in Experimental Autoimmune Encephalomyelitis Mice

Research on Macrophages, Tcells and TLR/NF- B Pathway in EAE Mice Treated with Oral Fasudil

Anti-inflammatory Effect of Fasudil in Treating Experimental Autoimmune Encephalomyelitis

Fasudil Ameliorates Disease Progression in Experimental Autoimmune Encephalomyelitis, Acting Possibly Through Antiinflammatory Effect.

Fasudil Inhibits the Infiltration of Inflammatory Cells by Upregulating Occludin Expression in Experimental Autoimmune Encephalomyelitis Mice

Neuroprotective effect of fasudil combined with bone marrow-derived neural stem cells on mice with experimental autoimmune encephalomyelitis

Fasudil-modified Macrophages Reduce Inflammation and Regulate the Immune Response in Experimental Autoimmune Encephalomyelitis.

Targeting the Shift from M1 to M2 Macrophages in Experimental Autoimmune Encephalomyelitis Mice Treated with Fasudil.

Effect of Fasudil on Experimental Autoimmune Neuritis and Its Mechanisms of Action

Synergistic and Superimposed Effect of Bone Marrow-Derived Mesenchymal Stem Cells Combined with Fasudil in Experimental Autoimmune Encephalomyelitis

The Immunoregulatory Effect of Rho Kinase Inhibitor Fasudil on Macrophages in a Mouse Model of ;experimental Autoimmune Encephalomyelitis

Hydroxyfasudil regulates immune balance and suppresses inflammatory responses in the treatment of experimental autoimmune encephalomyelitis

Changes of Synapses in Experimental Autoimmune Encephalomyelitis by Using Fasudil.

Therapeutic Potential of Experimental Autoimmune Encephalomyelitis by Fasudil, A Rho Kinase Inhibitor

Research about protective effects of fasudil on BBB function in EAE mice and study of the mechanisms

Intranasal Delivery of FSD‐C10, a Novel Rho Kinase Inhibitor, Exhibits Therapeutic Potential in Experimental Autoimmune Encephalomyelitis

The Inhibition of Rho Kinase Blocks Cell Migration and Accumulation Possibly by Challenging Inflammatory Cytokines and Chemokines on Astrocytes.